CoreRx, Inc. Press Releases - EIN Presswire - Press Release Distribution Service

Published on December 15, 2021 - 14:00 GMT

CoreRx Announces addition of Ryan McFarlane as Executive Director, Operational Excellence

Addition bolsters Executive Leadership Team CLEARWATER, FLORIDA, USA, December 15, 2021 /⁨EINPresswire.com⁩/ -- CoreRx is pleased to announce the recent appointment of Ryan McFarlane as Executive Director, Operational Excellence. Ryan will be …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 22, 2021 - 14:00 GMT

CoreRx Announces Successful US FDA Inspection of Clearwater Facility

Site Achieves “No Action Indicated” Status CLEARWATER, FLORIDA, USA, November 22, 2021 /⁨EINPresswire.com⁩/ -- CoreRx is pleased to announce that the U.S. Food and Drug Administration (FDA) has issued their Establishment Inspection Report (EIR) for FEI …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 2, 2021 - 13:00 GMT

CoreRx Announces New Leadership of Commercial Team

Leadership appointment follows expansion of Business Development team CLEARWATER, FLORIDA, UNITED STATES, August 2, 2021 /⁨EINPresswire.com⁩/ -- CoreRx is pleased to announcement the recent appointment of Hank Nowak as the Executive Director, Head of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on July 1, 2021 - 13:30 GMT

CoreRx Adds Investment to Expand Oral Dosage Form Capabilities

Investment Will Enhance Development, Scale-up, and Tech Transfer Capabilities Across its US Sites CLEARWATER, FLORIDA, UNITED STATES, July 1, 2021 /⁨EINPresswire.com⁩/ -- CoreRx, Inc. announced today that it is adding investment in formulation development …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on June 1, 2021 - 13:30 GMT

CoreRx, Inc. names Deborah Wild as Executive Chairwoman of the Board

CLEARWATER, FLORIDA, UNITED STATES, June 1, 2021 /⁨EINPresswire.com⁩/ -- CoreRx, Inc., is pleased to announce the appointment of Deborah Wild as the Executive Chairwoman of the Board. Deborah is an accomplished C-Suite executive bringing a wealth of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 24, 2021 - 12:00 GMT

CoreRx Acquires Nucleo Life Sciences

Acquisition Creates Unparalleled East / West Coast Development Services Presence in the US CLEARWATER, FLORIDA, UNITED STATES, May 24, 2021 /⁨EINPresswire.com⁩/ -- CoreRx, Inc. announced today the acquisition of Nucleo Life Sciences, a boutique CDMO based …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on April 30, 2021 - 13:30 GMT

CoreRx Inc. receives approval for Schedule I controlled drug manufacture

Approval now extends ability to develop and manufacture all scheduled drug classifications CLEARWATER, FLORIDA, USA, April 30, 2021 /⁨EINPresswire.com⁩/ -- CoreRx, Inc., is pleased to announce that they have received approval from the Federal Drug …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on January 19, 2021 - 12:00 GMT

NovaQuest Private Equity Acquires CoreRx, Inc.

New Strategic Financial Sponsor to Support Continued Growth and Capability Expansion CLEARWATER, FLORIDA, UNITED STATES, January 19, 2021 /⁨EINPresswire.com⁩/ -- NovaQuest Private Equity Acquires CoreRx, Inc. New Strategic Financial Sponsor to Support …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 4, 2020 - 12:00 GMT

CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER

CoreRx, Inc. Fully operational in the new product development center– Company to Continue Investments to Support Growing Client Demands CLEARWATER, FL, UNITED STATES, August 4, 2020 /⁨EINPresswire.com⁩/ -- CoreRx, Inc., a global contract development and …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on March 27, 2020 - 11:45 GMT

CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with Bionpharma Inc.

CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc. CLEARWATER, FL, USA, March 27, 2020 /⁨EINPresswire.com⁩/ -- CoreRx, Inc. announces the approval and pending commercial …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on October 29, 2019 - 12:00 GMT

CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING PRODUCT DEVELOPMENT CAPACITY 

CLEARWATER, FL, UNITED STATES, October 29, 2019 /⁨EINPresswire.com⁩/ -- CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING PRODUCT DEVELOPMENT CAPACITY  Company to Continue Investments, Increase Workforce For immediate release: 10/ …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on June 3, 2019 - 11:30 GMT

CoreRx, Inc. announces that its client Bionpharma Inc. has received FDA approval for generic oral suspension Banzel®

CoreRx, Inc. announces that its client Bionpharma Inc. has received FDA approval for generic oral suspension Banzel®(Rufinamide) CLEARWATER, FL, UNITED STATES, June 3, 2019 /⁨EINPresswire.com⁩/ -- CoreRx, Inc. announces that its client Bionpharma Inc. has …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on May 14, 2019 - 11:00 GMT

CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment

CoreRx, Inc. announces commercial supply agreement for peanut allergy treatment CLEARWATER, FL, USA, May 14, 2019 /⁨EINPresswire.com⁩/ -- CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on March 18, 2019 - 12:00 GMT

CORERX, INC. ADDS INCREASING PRODUCT DEVELOPMENT CAPACITY

Company to Continue Investments, Increase Workforce CLEARWATER, FLORIDA, UNITED STATES, March 18, 2019 /⁨EINPresswire.com⁩/ -- CORERX, INC. ADDS INCREASING PRODUCT DEVELOPMENT CAPACITY Company to Continue Investments, Increase Workforce For immediate …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on November 2, 2018 - 15:50 GMT

CoreRx, Inc. announces that its client Bionpharma has received FDA approval for a generic version of ONFI® (Clobazam)

CLEARWATER, FLORIDA, UNITED STATES, November 2, 2018 /⁨EINPresswire.com⁩/ -- CoreRx, Inc. announces that its client Bionpharma has received FDA approval for a generic version of ONFI® (Clobazam) Oral Suspension, 2.5mg/mL. Clobazam Oral Suspension is …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...